ResearcherEdward Hines, Jr. VA HospitalActive in the last 2 years
Marshall S. Baker
Matched on OpenAlex author ID A5103817172. Sources: OpenAlex.
Their work
- Papers
- 9 (first author 0, last author 6)
- Trials
- 0
- Grants
- 0
- Labs led
- 2
- Collaborators
- 24
2014: 1 paper · 2015: none · 2016: 2 papers · 2017: 1 paper · 2018: 2 papers · 2019: none · 2020: 1 paper · 2021: none · 2022: none · 2023: none · 2024: 2 papers
Papers 9
- Locally advanced pancreatic cancer: Is surgical palliation associated with improved clinical outcome relative to medical palliation? Last author DOI 10.1016/j.amjsurg.2024.01.017↗
- Fragmented care in localized pancreatic cancer: Is commission on cancer accreditation associated with improved overall survival? Last author DOI 10.1016/j.surg.2023.08.040↗
- Assessment of textbook oncologic outcomes following pancreaticoduodenectomy for pancreatic adenocarcinoma. Co-author DOI 10.1002/jso.25861↗
- Primary systemic therapy in resectable pancreatic ductal adenocarcinoma using mFOLFIRINOX: A pilot study. Co-author DOI 10.1002/jso.24872↗
- Does adjuvant radiation provide any survival benefit after an R1 resections for pancreatic cancer? Last author DOI 10.1016/j.surg.2017.09.022↗
- Neoadjuvant external beam radiation is associated with No benefit in overall survival for early stage pancreatic cancer. Last author DOI 10.1016/j.amjsurg.2016.11.039↗
- A Graded Evaluation of Outcomes Following Pancreaticoduodenectomy with Major Vascular Resection in Pancreatic Cancer. Last author DOI 10.1007/s11605-015-2957-2↗
- External radiation is associated with limited improvement in overall survival in resected margin-negative stage IIB pancreatic adenocarcinoma. Last author DOI 10.1016/j.surg.2016.07.033↗
- CA 19-9 nonproduction is associated with poor survival after resection of pancreatic adenocarcinoma. Co-author DOI 10.1097/coc.0b013e318280d5f0↗
Closest collaborators
The 24 strongest of 24 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Marina Talamonti · 6 shared papers, 2014–2018 · strength 0.38
- Paper Primary systemic therapy in resectable pancreatic ductal adenocarcinoma using mFOLFIRINOX: A pilot study. DOI 10.1002/jso.24872↗
- Paper Does adjuvant radiation provide any survival benefit after an R1 resections for pancreatic cancer? DOI 10.1016/j.surg.2017.09.022↗
- Paper Neoadjuvant external beam radiation is associated with No benefit in overall survival for early stage pancreatic cancer. DOI 10.1016/j.amjsurg.2016.11.039↗
- Robert Marsh · 5 shared papers, 2014–2018 · strength 0.32
- Paper Primary systemic therapy in resectable pancreatic ductal adenocarcinoma using mFOLFIRINOX: A pilot study. DOI 10.1002/jso.24872↗
- Paper Does adjuvant radiation provide any survival benefit after an R1 resections for pancreatic cancer? DOI 10.1016/j.surg.2017.09.022↗
- Paper Neoadjuvant external beam radiation is associated with No benefit in overall survival for early stage pancreatic cancer. DOI 10.1016/j.amjsurg.2016.11.039↗
- Richard A. Prinz · 5 shared papers, 2014–2018 · strength 0.31
- Paper Does adjuvant radiation provide any survival benefit after an R1 resections for pancreatic cancer? DOI 10.1016/j.surg.2017.09.022↗
- Paper Neoadjuvant external beam radiation is associated with No benefit in overall survival for early stage pancreatic cancer. DOI 10.1016/j.amjsurg.2016.11.039↗
- Paper A Graded Evaluation of Outcomes Following Pancreaticoduodenectomy with Major Vascular Resection in Pancreatic Cancer. DOI 10.1007/s11605-015-2957-2↗
- David J. Bentrem · 4 shared papers, 2014–2018 · strength 0.25
- Paper Does adjuvant radiation provide any survival benefit after an R1 resections for pancreatic cancer? DOI 10.1016/j.surg.2017.09.022↗
- Paper Neoadjuvant external beam radiation is associated with No benefit in overall survival for early stage pancreatic cancer. DOI 10.1016/j.amjsurg.2016.11.039↗
- Paper A Graded Evaluation of Outcomes Following Pancreaticoduodenectomy with Major Vascular Resection in Pancreatic Cancer. DOI 10.1007/s11605-015-2957-2↗
- Sarah P Kramer · 1 shared paper, 2024 · strength 0.24
- Simon Jigwan Park · 1 shared paper, 2024 · strength 0.22
- Kevin King Roggin · 3 shared papers, 2017–2018 · strength 0.21
- Paper Primary systemic therapy in resectable pancreatic ductal adenocarcinoma using mFOLFIRINOX: A pilot study. DOI 10.1002/jso.24872↗
- Paper Does adjuvant radiation provide any survival benefit after an R1 resections for pancreatic cancer? DOI 10.1016/j.surg.2017.09.022↗
- Paper Neoadjuvant external beam radiation is associated with No benefit in overall survival for early stage pancreatic cancer. DOI 10.1016/j.amjsurg.2016.11.039↗
- Olga Kantor · 3 shared papers, 2016–2017 · strength 0.19
- Paper Neoadjuvant external beam radiation is associated with No benefit in overall survival for early stage pancreatic cancer. DOI 10.1016/j.amjsurg.2016.11.039↗
- Paper A Graded Evaluation of Outcomes Following Pancreaticoduodenectomy with Major Vascular Resection in Pancreatic Cancer. DOI 10.1007/s11605-015-2957-2↗
- Paper External radiation is associated with limited improvement in overall survival in resected margin-negative stage IIB pan… DOI 10.1016/j.surg.2016.07.033↗
- Waseem Lutfi · 2 shared papers, 2016–2017 · strength 0.13
- Paper Neoadjuvant external beam radiation is associated with No benefit in overall survival for early stage pancreatic cancer. DOI 10.1016/j.amjsurg.2016.11.039↗
- Paper External radiation is associated with limited improvement in overall survival in resected margin-negative stage IIB pan… DOI 10.1016/j.surg.2016.07.033↗
- Patrick J. Sweigert · 1 shared paper, 2020 · strength 0.11
- Anghela Z. Paredes · 1 shared paper, 2020 · strength 0.11
- Diamantis I. Tsilimigras · 1 shared paper, 2020 · strength 0.11
- Allan Tsung · 1 shared paper, 2020 · strength 0.11
- Jordan M. Cloyd · 1 shared paper, 2020 · strength 0.11
- Timothy Michael Pawlik · 1 shared paper, 2020 · strength 0.11
- Mary E. Dillhoff · 1 shared paper, 2020 · strength 0.11
- Aslam M. Ejaz · 1 shared paper, 2020 · strength 0.11
- Jeffrey B. Matthews · 1 shared paper, 2018 · strength 0.07
- Mitchell C. Posner · 1 shared paper, 2018 · strength 0.07
- Daniel V.T. Catenacci · 1 shared paper, 2018 · strength 0.07
- Hedy Lee Kindler · 1 shared paper, 2018 · strength 0.07
- Blasé N. Polite · 1 shared paper, 2018 · strength 0.07
- Nicholas R. Suss · 1 shared paper, 2018 · strength 0.07
- Amanda V. Hayman · 1 shared paper, 2014 · strength 0.05
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.